SCHEMBL2049005

SCHEMBL2049005

NCCC(=O)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Alpha-Ketoglutaric Acid SCHEMBL1261453 0.83 EGLN1 (0.74)
SCHEMBL728986 0.81
SCHEMBL728991 0.79 NFKB1 (0.62)
Hydrochloric Acid SCHEMBL28408226 0.79 BLM (0.57)
SCHEMBL1673131 0.79 OR51E2 (0.40)
SCHEMBL361798 0.78 OR51E2 (0.79)
SCHEMBL28754323 0.77 OR51E2 (0.44)
SCHEMBL285020 0.77 LMNA (0.64)
SCHEMBL2368877 0.77 LMNA (0.64)
SCHEMBL16585547 0.77 HAO1 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115666653-A Antibody-drug conjugates 斯皮雷亚有限公司 2023-01-31 CN claimed
CN-103896940-B A kind of synthetic method of Eliquis CHEMFUTURE PHARMATECH (JIANGSU), LTD. (CN) 2016-02-03 CN claimed
CN-103896940-A Synthetic method of Apixaban CHEMFUTURE PHARMATECH JIANGSU LTD 2014-07-02 CN claimed
CN-115666653-A Antibody-drug conjugates 斯皮雷亚有限公司 2023-01-31 CN disclosed
US-20220054649-A1 ANTIBODY-DRUG CONJUGATES SPIREA LIMITED (GB) 2022-02-24 US disclosed
EP-3897744-A1 ANTIBODY-DRUG CONJUGATES Spirea Limited (GB) 2021-10-27 EP disclosed
CN-113226378-A Antibody-drug conjugates 斯皮雷亚有限公司 2021-08-06 CN disclosed
CN-111171041-B 20-substituted camptothecin derivative and preparation method and application thereof 中国海洋大学 2021-07-27 CN disclosed
WO-2020128488-A1 ANTIBODY-DRUG CONJUGATES SPIREA LIMITED (GB) 2020-06-25 WO disclosed
CN-111171041-A 20-substituted camptothecin derivative and preparation method and application thereof 中国海洋大学 2020-05-19 CN disclosed
CN-110003123-A For treating the PGI2 receptor modulators of prostacyclin (PGI2) receptor associate disorder 艾尼纳制药公司 2019-07-12 CN disclosed
WO-2010011998-A1 ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2010-01-28 WO disclosed
WO-2009085072-A1 COMPOSITION COMPRISING CHELATING AGENTS CONTAINING AMIDOXIME COMPOUNDS EKC TECHNOLOGY, INC (US) 2009-07-09 WO disclosed
WO-2009058274-A1 CHEMICAL MECHANICAL POLISHING AND WAFER CLEANING COMPOSITION COMPRISING AMIDOXIME COMPOUNDS AND ASSOCIATED METHOD FOR USE EKC TECHNOLOGY, INC. (US) 2009-05-07 WO disclosed
WO-2009058272-A1 COPPER CMP POLISHING PAD CLEANING COMPOSITION COMPRISING OF AMIDOXIME COMPOUNDS EKC TECHNOLOGY, INC. (US) 2009-05-07 WO disclosed
WO-2009058275-A1 METHODS OF POST CHEMICAL MECHANICAL POLISHING AND WAFER CLEANING USING AMIDOXIME COMPOSITIONS EKC TECHNOLOGY, INC. (US) 2009-05-07 WO disclosed
WO-2009058278-A1 METHODS OF CLEANING SEMICONDUCTOR DEVICES AT THE BACK END OF LINE USING AMIDOXIME COMPOSITIONS EKC TECHNOLOGY, INC (US) 2009-05-07 WO disclosed
WO-2009058288-A1 AMIDOXIME COMPOUNDS AS CHELATING AGENTS IN SEMICONDUCTOR PROCESSES EKC TECHNOLOGY, INC. (US) 2009-05-07 WO disclosed
JP-2007106706-A METHOD FOR PRODUCING OPTICALLY ACTIVE AMINO ALCOHOL TAKASAGO INTERNATL CORP 2007-04-26 JP disclosed
US-4740531-A REACTION INJECTION MOLDING MATERIALS; LOW VISCOSITY; COMPACT SURFACES BAYER AKTIENGESELLSCHAFT (DE) 1988-04-26 US disclosed